Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Gavin Clark-Gartner is an analyst at Evercore ISI Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/16/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/12/2024 | ARGX | Buy Now | argenx | $461.94 | 15.38% | $478 → $533 | Maintains | Outperform | Get Alert |
| 06/24/2024 | SRPT | Buy Now | Sarepta Therapeutics | $152.60 | 21.23% | $139 → $185 | Maintains | In-Line | Get Alert |
| 04/03/2024 | JSPR | Buy Now | Jasper Therapeutics | $19.92 | 226.31% | → $65 | Initiates | → Outperform | Get Alert |
| 02/20/2024 | SRPT | Buy Now | Sarepta Therapeutics | $152.60 | -9.57% | $108 → $138 | Maintains | In-Line | Get Alert |
| 12/21/2023 | ARGX | Buy Now | argenx | $461.94 | -5.62% | $594 → $436 | Maintains | Outperform | Get Alert |
| 10/17/2023 | MIRM | Buy Now | Mirum Pharmaceuticals | $39.00 | 58.97% | → $62 | Reinstates | → Outperform | Get Alert |
| 10/03/2023 | ACRS | Buy Now | Aclaris Therapeutics | $1.32 | 1566.67% | → $22 | Initiates | → Outperform | Get Alert |
| 07/17/2023 | ARGX | Buy Now | argenx | $461.94 | -5.62% | → $436 | Reinstates | → Outperform | Get Alert |
| 06/23/2023 | SRPT | Buy Now | Sarepta Therapeutics | $152.60 | -8.91% | → $139 | Downgrade | Outperform → Neutral | Get Alert |
| 05/30/2023 | SRPT | Buy Now | Sarepta Therapeutics | $152.60 | -1.05% | $173 → $151 | Maintains | Outperform | Get Alert |
| 05/30/2023 | CCCC | Buy Now | C4 Therapeutics | $6.30 | 58.73% | $20 → $10 | Maintains | Outperform | Get Alert |
| 05/15/2023 | SRPT | Buy Now | Sarepta Therapeutics | $152.60 | 13.37% | $149 → $173 | Maintains | Outperform | Get Alert |
| 04/13/2023 | SRPT | Buy Now | Sarepta Therapeutics | $152.60 | -2.36% | → $149 | Maintains | Outperform | Get Alert |
| 03/01/2023 | SRPT | Buy Now | Sarepta Therapeutics | $152.60 | 12.06% | $135 → $171 | Maintains | Outperform | Get Alert |
| 02/09/2023 | ABBV | Buy Now | AbbVie | $168.03 | -1.8% | $159 → $165 | Maintains | Outperform | Get Alert |
| 12/20/2022 | ABBV | Buy Now | AbbVie | $168.03 | -8.35% | $156 → $154 | Maintains | Outperform | Get Alert |
| 10/05/2022 | INBX | Buy Now | Inhibrx | $13.86 | 332.9% | $54 → $60 | Maintains | Outperform | Get Alert |
